drugset / Trial / NCT03640624
Multidisciplinary Treatment of Chronic Vulvar Pain
Active not recruiting
106 enrolled
Norwegian University of Science and Technology
St. Olavs Hospital · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
Vulvodynia (i.e. chronic vulvar pain without identifiable cause) is a heterogeneous clinical entity with a complex multifactorial causation. It is long lasting and difficult to treat, and the general consensus of current guidelines states that patients with vulvodynia benefit from a compound multidisciplinary intervention targeting mucosal hypersensitivity, pelvic muscle floor dysfunction and general pain management. However, there is little empiric evidence to support this recommendation. This will be a randomized controlled trial comparing multidisciplinary treatment with standard care for women with vulvodynia.
Timeline
- Start
- 2018-09-18
- Primary completion
- 2024-11-10
- Completion
- 2027-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Lidocaine | Other / unclassified | 5 % | Topical |